Cargando…
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer
PURPOSE OF REVIEW: HER2-targeted therapies have led to improved clinical outcomes in early and advanced breast cancer (BC). We review the long-term cardiotoxicity of HER2-targeted therapy in early and advanced BC, our current knowledge of cardiotoxicity of novel HER2-targeted therapies, and propose...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395382/ https://www.ncbi.nlm.nih.gov/pubmed/34453232 http://dx.doi.org/10.1007/s11912-021-01114-x |